What is the current valuation of the In Vitro Fertilization Market?

As of 2024, the market was valued at 26.52 USD Billion. Read More

What is the projected market size for the In Vitro Fertilization Market in 2035?

The market is projected to reach 40.01 USD Billion by 2035. Read More

What is the expected CAGR for the market from 2025 to 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 3.81%. Read More

Which segment of the In Vitro Fertilization Market had the highest valuation in 2024?

In 2024, the Traditional IVF segment had the highest valuation at 10.0 to 15.0 USD Billion. Read More

What are the projected values for the Cryopreservation segment by 2035?

The Cryopreservation segment is projected to reach between 4.5 to 6.0 USD Billion by 2035. Read More

Which key players are leading the In Vitro Fertilization Market?

Key players in the market include IVF Australia, Fertility Centers of Illinois, and CCRM Fertility, among others. Read More

What is the market valuation for the Female Infertility patient type in 2024?

The market valuation for the Female Infertility patient type was between 15.0 to 23.0 USD Billion in 2024. Read More

How does the market for Fertility Clinics compare to Hospitals in 2024?

In 2024, the market for Fertility Clinics was valued at 10.0 to 15.0 USD Billion, whereas Hospitals were valued at 8.0 to 12.0 USD Billion. Read More

What is the projected growth for the Instruments product type by 2035?

The Instruments product type is projected to grow to between 9.5 to 12.0 USD Billion by 2035. Read More

What is the expected market size for Unexplained Infertility by 2035?

The market size for Unexplained Infertility is expected to reach between 9.51 to 12.0 USD Billion by 2035. Read More

In-Vitro Fertilization (IVF) Market

ID: MRFR/HC/1682-CR

200 Pages

Satyendra Maurya

Last Updated: April 02, 2026

In Vitro Fertilization Market Research Report: Size, Share, Trend Analysis By Technique (Intra-Cytoplasmic Sperm Injection, Traditional IVF, Preimplantation Genetic Testing, Cryopreservation, Embryo Culture), By Product Type (Instruments, Media, Consumables), By End Users (Fertility Clinics, Hospitals, Research Laboratories), By Patient Type (Male Infertility, Female Infertility, Unexplained Infertility) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2026 To 2035

In-Vitro Fertilization (IVF) Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.4%

2025 Market Size$ 29 Billion

2026 Market Size$ 31.7 Billion

2035 Market Size$ 71.3 Billion

Key Players

Companies such as IVF Australia

 Fertility Centers of Illinois

CCRM Fertility

New Hope Fertility Center

Reproductive Health Specialists

IVF Spain

Trends

Technological Advancements
Increased Awareness and Acceptance
Personalized Treatment Approaches

Opportunities

Changing Societal Norms
Rising Infertility Rates
Technological Innovations

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Technique (USD Billion) | |
  1. 4.1.1 Intra-Cytoplasmic Sperm Injection | |
  2. 4.1.2 Traditional IVF | |
  3. 4.1.3 Preimplantation Genetic Testing | |
  4. 4.1.4 Cryopreservation | |
  5. 4.1.5 Embryo Culture |
2. 4.2 Healthcare, BY Product Type (USD Billion) | |
  1. 4.2.1 Instruments | |
  2. 4.2.2 Media | |
  3. 4.2.3 Consumables |
3. 4.3 Healthcare, BY End User (USD Billion) | |
  1. 4.3.1 Fertility Clinics | |
  2. 4.3.2 Hospitals | |
  3. 4.3.3 Research Laboratories |
4. 4.4 Healthcare, BY Patient Type (USD Billion) | |
  1. 4.4.1 Male Infertility | |
  2. 4.4.2 Female Infertility | |
  3. 4.4.3 Unexplained Infertility |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 IVF Australia (AU) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Fertility Centers of Illinois (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 CCRM Fertility (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 New Hope Fertility Center (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Reproductive Health Specialists (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 IVF Spain (ES) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Clinica Tambre (ES) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Bourn Hall Clinic (GB) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 IVF Clinic (RU) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY TECHNIQUE |
7. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 US MARKET ANALYSIS BY PATIENT TYPE |
10. 6.7 CANADA MARKET ANALYSIS BY TECHNIQUE |
11. 6.8 CANADA MARKET ANALYSIS BY PRODUCT TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY END USER |
13. 6.10 CANADA MARKET ANALYSIS BY PATIENT TYPE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY TECHNIQUE |
16. 6.13 GERMANY MARKET ANALYSIS BY PRODUCT TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY END USER |
18. 6.15 GERMANY MARKET ANALYSIS BY PATIENT TYPE |
19. 6.16 UK MARKET ANALYSIS BY TECHNIQUE |
20. 6.17 UK MARKET ANALYSIS BY PRODUCT TYPE |
21. 6.18 UK MARKET ANALYSIS BY END USER |
22. 6.19 UK MARKET ANALYSIS BY PATIENT TYPE |
23. 6.20 FRANCE MARKET ANALYSIS BY TECHNIQUE |
24. 6.21 FRANCE MARKET ANALYSIS BY PRODUCT TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY END USER |
26. 6.23 FRANCE MARKET ANALYSIS BY PATIENT TYPE |
27. 6.24 RUSSIA MARKET ANALYSIS BY TECHNIQUE |
28. 6.25 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY END USER |
30. 6.27 RUSSIA MARKET ANALYSIS BY PATIENT TYPE |
31. 6.28 ITALY MARKET ANALYSIS BY TECHNIQUE |
32. 6.29 ITALY MARKET ANALYSIS BY PRODUCT TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY END USER |
34. 6.31 ITALY MARKET ANALYSIS BY PATIENT TYPE |
35. 6.32 SPAIN MARKET ANALYSIS BY TECHNIQUE |
36. 6.33 SPAIN MARKET ANALYSIS BY PRODUCT TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY END USER |
38. 6.35 SPAIN MARKET ANALYSIS BY PATIENT TYPE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNIQUE |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY PATIENT TYPE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY TECHNIQUE |
45. 6.42 CHINA MARKET ANALYSIS BY PRODUCT TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY END USER |
47. 6.44 CHINA MARKET ANALYSIS BY PATIENT TYPE |
48. 6.45 INDIA MARKET ANALYSIS BY TECHNIQUE |
49. 6.46 INDIA MARKET ANALYSIS BY PRODUCT TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY END USER |
51. 6.48 INDIA MARKET ANALYSIS BY PATIENT TYPE |
52. 6.49 JAPAN MARKET ANALYSIS BY TECHNIQUE |
53. 6.50 JAPAN MARKET ANALYSIS BY PRODUCT TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY END USER |
55. 6.52 JAPAN MARKET ANALYSIS BY PATIENT TYPE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY PATIENT TYPE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY TECHNIQUE |
61. 6.58 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY END USER |
63. 6.60 MALAYSIA MARKET ANALYSIS BY PATIENT TYPE |
64. 6.61 THAILAND MARKET ANALYSIS BY TECHNIQUE |
65. 6.62 THAILAND MARKET ANALYSIS BY PRODUCT TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY END USER |
67. 6.64 THAILAND MARKET ANALYSIS BY PATIENT TYPE |
68. 6.65 INDONESIA MARKET ANALYSIS BY TECHNIQUE |
69. 6.66 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY END USER |
71. 6.68 INDONESIA MARKET ANALYSIS BY PATIENT TYPE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY TECHNIQUE |
73. 6.70 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY END USER |
75. 6.72 REST OF APAC MARKET ANALYSIS BY PATIENT TYPE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY TECHNIQUE |
78. 6.75 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY END USER |
80. 6.77 BRAZIL MARKET ANALYSIS BY PATIENT TYPE |
81. 6.78 MEXICO MARKET ANALYSIS BY TECHNIQUE |
82. 6.79 MEXICO MARKET ANALYSIS BY PRODUCT TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY END USER |
84. 6.81 MEXICO MARKET ANALYSIS BY PATIENT TYPE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY TECHNIQUE |
86. 6.83 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY END USER |
88. 6.85 ARGENTINA MARKET ANALYSIS BY PATIENT TYPE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUE |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT TYPE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNIQUE |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY PATIENT TYPE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNIQUE |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY PATIENT TYPE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY TECHNIQUE |
103. 6.100 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY END USER |
105. 6.102 REST OF MEA MARKET ANALYSIS BY PATIENT TYPE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY TECHNIQUE, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY TECHNIQUE, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY PATIENT TYPE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY PATIENT TYPE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY TECHNIQUE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY PRODUCT TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY PATIENT TYPE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

In Vitro Fertilization Market Segmentation

In Vitro Fertilization Market By Technique (USD Billion, 2025-2035)

Intra-Cytoplasmic Sperm Injection
Traditional IVF
Preimplantation Genetic Testing
Cryopreservation
Embryo Culture

In Vitro Fertilization Market By Product Type (USD Billion, 2025-2035)

Instruments
Media
Consumables

In Vitro Fertilization Market By End User (USD Billion, 2025-2035)

Fertility Clinics
Hospitals
Research Laboratories

In Vitro Fertilization Market By Patient Type (USD Billion, 2025-2035)

Male Infertility
Female Infertility
Unexplained Infertility

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”